Monograph Capital Partners I, L.P. investment portfolio

Ascend Advanced Therapies Limited provides development‑partner services and analytics platforms that support the creation and scaling of advanced therapies such as gene therapies, immunotherapies, oncolytic agents and vaccines for biotech and pharmaceutical companies.

AviadoBio creates gene‑therapy medicines and delivery technologies that target neurodegenerative disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer’s disease, tauopathies and retinal conditions. Its platform combines next‑generation gene‑therapy design with neuroscience expertise and a neuroanatomy‑led approach to deliver treatments to the brain and eye.